A sudden CPU spike turned out to be the first clue of an in-progress RansomHub ransomware attack. Varonis breaks down how ...

Anavex Life Sciences faces regulatory setbacks, pipeline doubts, and dilution risks. Click here to read my latest analysis of ...

The Akira ransomware group has made over $244 million in proceeds from its malicious activities, according to government ...

Maverick malware spreads via WhatsApp Web, targeting Brazilian banks through PowerShell and browser hijacking.

Q3 2025 Earnings Call Transcript November 12, 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is ...

Appointed key leadership to drive (Z)-endoxifen development and evolve pathway to commercialization SEATTLE, /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third ...

Net (Loss) Income: The net loss attributable to Serina for the three months ended September 30, 2025 was $4.6 million, or $0.45 per basic and diluted share, compared to net income of $1.4 million, or ...

Company’s strategic focus and highest priority is now the advancement of the 4WARD Phase 3 chronic neutropenia ...

Discover Rhythm Pharmaceuticals’ Q3 2025 earnings insights, IMCIVREE launch updates, regulatory milestones, and global growth plans.

Serina Therapeutics, Inc. ("Serina" or the "Company") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational New ...

NEW YORK, November 13, 2025 – Immunic, Inc. ( Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today ...